This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bamberger, A. M. Articles by Loning, T. Search for Related Content PubMed PubMed Citation Articles by Bamberger, A. M. Articles by Loning, T.

American Journal of Pathology, Vol 152, 1401-1406, Copyright © 1998 by American Society for Investigative Pathology

REGULAR ARTICLES

Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer

AM Bamberger, L Riethdorf, P Nollau, M Naumann, I Erdmann, J Gotze, J Brummer, HM Schulte, C Wagener and T Loning
Department of Gynecopathology, University Hospital Eppendorf, Hamburg, Germany.

CD66a (BGP, C-CAM) is an adhesion molecule of the carcinoembryonic antigen family that has been shown to be down-regulated in colorectal, prostate, and breast cancers. The purpose of the present study was to determine its expression pattern in the normal human endometrium and in endometrial neoplasia. For this purpose, we performed immunohistochemistry using the 4D1/C2 monoclonal antibody on a series of 24 normal endometrial samples and 47 endometrial carcinomas. Strong CD66a expression was observed in glandular and luminal epithelial cells of the normal endometrium with a consistent localization at the apical poles of these cells throughout the cycle. In late secretory (premenstrual) phase, loss of cellular polarity resulted in a membranous expression pattern in some glandular cells. In the analyzed tumor samples increasing areas with a complete loss of expression were observed with increasing malignancy grade. The apical expression pattern of the normal epithelium was changed to a membranous all-around pattern in 55% of the tumors, mostly in solid areas. This change correlated with malignancy grade and could be observed in 3 of 15 G1 tumors, 4 of 12 G2 tumors, 11 of 12 G3 tumors, and 8 of 8 serous- papillary carcinomas. Areas with membranous expression pattern could be observed along with areas with a normal apical expression pattern in lower grade carcinomas and with areas with complete loss of expression in high grade tumors. Northern blot analysis showed a loss of mRNA expression in tumor samples and HEC-1B endometrial adenocarcinoma cells. Loss of protein expression in the tumor samples was also observed by Western blot. In conclusion, CD66a protein expression is dysregulated in endometrial carcinomas, showing reduction or loss of expression with increasing malignancy grade and a change from the apical to a membranous localization.

This article has been cited by other articles:

				Q. Yu, E. M. C. Chow, H. Wong, J. Gu, O. Mandelboim, S. D. Gray-Owen, and M. A. Ostrowski CEACAM1 (CD66a) Promotes Human Monocyte Survival via a Phosphatidylinositol 3-Kinase- and AKT-dependent Pathway J. Biol. Chem., December 22, 2006; 281(51): 39179 - 39193. [Abstract] [Full Text] [PDF]

				A.-M. Bamberger, J. Briese, J. Gotze, I. Erdmann, H. M. Schulte, C. Wagener, and P. Nollau Stimulation of CEACAM1 expression by 12-O-tetradecanoylphorbol-13-acetate (TPA) and calcium ionophore A23187 in endometrial carcinoma cells Carcinogenesis, March 1, 2006; 27(3): 483 - 490. [Abstract] [Full Text] [PDF]

				A.-M. Bamberger, V. Minas, S. N. Kalantaridou, J. Radde, H. Sadeghian, T. Loning, I. Charalampopoulos, J. Brummer, C. Wagener, C. M. Bamberger, et al. Corticotropin-Releasing Hormone Modulates Human Trophoblast Invasion through Carcinoembryonic Antigen-Related Cell Adhesion Molecule-1 Regulation Am. J. Pathol., January 1, 2006; 168(1): 141 - 150. [Abstract] [Full Text] [PDF]

				J. Briese, M. Oberndorfer, C. Patschenik, H. M. Schulte, A. Makrigiannakis, T. Loning, and A.-M. Bamberger Osteopontin Is Colocalized with the Adhesion Molecule CEACAM1 in the Extravillous Trophoblast of the Human Placenta and Enhances Invasion of CEACAM1-Expressing Placental Cells J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5407 - 5413. [Abstract] [Full Text] [PDF]

				D. Phan, C.-J. Cheng, M. Galfione, F. Vakar-Lopez, J. Tunstead, N. E. Thompson, R. R. Burgess, S. M. Najjar, L.-Y. Yu-Lee, and S.-H. Lin Identification of Sp2 as a Transcriptional Repressor of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Tumorigenesis Cancer Res., May 1, 2004; 64(9): 3072 - 3078. [Abstract] [Full Text] [PDF]

				W. Sienel, S. Dango, U. Woelfle, A. Morresi-Hauf, C. Wagener, J. Brummer, W. Mutschler, B. Passlick, and K. Pantel Elevated Expression of Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 Promotes Progression of Non-Small Cell Lung Cancer Clin. Cancer Res., June 1, 2003; 9(6): 2260 - 2266. [Abstract] [Full Text] [PDF]

				T. A. Plunkett and P. A. Ellis CEACAM1: A Marker With a Difference or More of the Same? J. Clin. Oncol., November 1, 2002; 20(21): 4273 - 4275. [Full Text] [PDF]

				O. Volpert, W. Luo, T.-J. Liu, V. T. Estrera, C. Logothetis, and S.-H. Lin Inhibition of Prostate Tumor Angiogenesis by the Tumor Suppressor CEACAM1 J. Biol. Chem., September 13, 2002; 277(38): 35696 - 35702. [Abstract] [Full Text] [PDF]

				A. Thies, I. Moll, J. Berger, C. Wagener, J. Brummer, H.-J. Schulze, G. Brunner, and U. Schumacher CEACAM1 Expression in Cutaneous Malignant Melanoma Predicts the Development of Metastatic Disease J. Clin. Oncol., May 15, 2002; 20(10): 2530 - 2536. [Abstract] [Full Text] [PDF]

				T. Chen, W. Zimmermann, J. Parker, I. Chen, A. Maeda, and S. Bolland Biliary glycoprotein (BGPa, CD66a, CEACAM1) mediates inhibitory signals J. Leukoc. Biol., August 1, 2001; 70(2): 335 - 340. [Abstract] [Full Text] [PDF]

				J. Brummer, A. Ebrahimnejad, R. Flayeh, U. Schumacher, T. Loning, A.-M. Bamberger, and C. Wagener cis Interaction of the Cell Adhesion Molecule CEACAM1 with Integrin {beta}3 Am. J. Pathol., August 1, 2001; 159(2): 537 - 546. [Abstract] [Full Text]

				R. Kammerer, D. Stober, B. B. Singer, B. Obrink, and J. Reimann Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 on Murine Dendritic Cells Is a Potent Regulator of T Cell Stimulation J. Immunol., June 1, 2001; 166(11): 6537 - 6544. [Abstract] [Full Text] [PDF]

				L. Wang, S. H. Lin, W. G. Wu, B. L. Kemp, G. L. Walsh, W. K. Hong, and L. Mao C-CAM1, a Candidate Tumor Suppressor Gene, Is Abnormally Expressed in Primary Lung Cancers Clin. Cancer Res., August 1, 2000; 6(8): 2988 - 2993. [Abstract] [Full Text]

				A.-M. Bamberger, S. Sudahl, T. Loning, C. Wagener, C. M. Bamberger, P. Drakakis, C. Coutifaris, and A. Makrigiannakis The Adhesion Molecule CEACAM1 (CD66a, C-CAM, BGP) Is Specifically Expressed by the Extravillous Intermediate Trophoblast Am. J. Pathol., April 1, 2000; 156(4): 1165 - 1170. [Abstract] [Full Text] [PDF]

				S. Sadekova, N. Lamarche-Vane, X. Li, and N. Beauchemin The CEACAM1-L Glycoprotein Associates with the Actin Cytoskeleton and Localizes to Cell-Cell Contact through Activation of Rho-like GTPases Mol. Biol. Cell, January 1, 2000; 11(1): 65 - 77. [Abstract] [Full Text]

				V. T. Estrera, D.-T. Chen, W. Luo, D. C. Hixson, and S.-H. Lin Signal Transduction by the CEACAM1 Tumor Suppressor. PHOSPHORYLATION OF SERINE 503 IS REQUIRED FOR GROWTH-INHIBITORY ACTIVITY J. Biol. Chem., April 27, 2001; 276(18): 15547 - 15553. [Abstract] [Full Text] [PDF]